产品说明书
TC ASK 10
 |
同义名 : | ASK1 Inhibitor 10 |
| CAS号 : | 1005775-56-3 | |
| 货号 : | A934694 | |
| 分子式 : | C21H23Cl2N5O | |
| 纯度 : | 98% | |
| 分子量 : | 432.346 | |
| MDL号 : | MFCD26792581 | |
| 存储条件： |
粉末 Inert atmosphere,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 105 mg/mL(242.86 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03696446 | Coronary Heart Disease | Not Applicable | Recruiting | December 31, 2020 | Canada, Ontario ... 展开 >> University of Ottawa Heart Institute Recruiting Ottawa, Ontario, Canada, K1Y 4W7 Contact: Evyanne Wooding 613-696-7000 ext 17596 ewooding@ottawaheart.ca 收起 << |
| NCT02267096 | Smoking Lung ... 展开 >>Cancer 收起 << | Phase 3 | Completed | - | United States, District of Col... 展开 >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Massachusetts Lahey Hospital and Medical Center Burlington, Massachusetts, United States, 01805 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
| NCT03107247 | Skeletal Injury | Phase 4 | Enrolling by invitation | March 31, 2021 | United States, Massachusetts ... 展开 >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.31mL 0.46mL 0.23mL |
11.56mL 2.31mL 1.16mL |
23.13mL 4.63mL 2.31mL |
